| Literature DB >> 30564222 |
Yaping Wang1, Aoyun Li1, Xiong Jiang1,2, Hui Zhang1, Khalid Mehmood1,3, Lihong Zhang1, Jinhuan Jiang1, Muhammad Waqas1, Mujahid Iqbal1, Jiakui Li1,4.
Abstract
The purpose of this study was to evaluate the antibacterial activity and safety of bacterias with probiotic potential isolated from free-ranging Tibetan yaks in high altitude regions of Tibet. For this purpose, one Leuconostoc pseudomesenteroides strain (named P1) and two Lactobacillus johnsonii and Lactobacillus mucosae strains (named LY1 and LY2), respectively, were isolated from fecal samples of Tibetan yaks. The antibacterial activity of the isolates was studied using Escherichia coli (E. coli ATCC 25922), Staphylococcus aureus (S. aureus ATCC 26112), and Salmonella enteritidis (S. enteritidis NCTC 13349) as indicator pathogens. The results showed that LY1 had high antibacterial efficacy against E. coli and S. enteritidis, while P1 had the most powerful bacteriostatic ability against S. aureus. PCR amplification showed that all the isolated strains were positive for Ent P2 (enterocin P-like bacteriocin) and exhibited a high tolerance to bile and low pH. Moreover, the safety of P1, LY1, and LY2 was determined through antibiotic resistance experiments, resistance gene testing, and hemolytic analysis while the antibacterial activity was assessed by in vitro and in vivo experiments. The LY2 strain was abandoned as a potential probiotic due to the detection of the vanA gene. The mice were fed from days 1 to 30 in six groups, the P1-1 (gavaged with P1 1 × 108 CFU/day), P1-2 (gavaged with P1 1 × 109 CFU/day), LY1-1 (gavaged with LY1 1 × 108 CFU/day), LY1-2 (gavaged with LY1 1 × 109 CFU/day), control (gavaged with an equal volume of vehicle), and blank control (gavaged with an equal volume of vehicle) groups. After 30 days, mice in the P1-1, P1-2, LY1-1, LY1-2, and control groups were intraperitoneal challenged with 1 × 108 CFU of E. coli (n = 10) in the abdomen. After 2 days of infection, the mice in the control group showed more severe damage in the liver, spleen and intestine than the mice in the P1-2 and LY1-2 groups. The mice in the P1-2 and LY1-2 groups had lower rates of diarrhea and mortality than other groups. In conclusion, bacteria with probiotic potential isolated from yaks may possibly be effective and safe antibacterial substances, providing a new treatment method to reduce the incidence of diarrhea associated with bacterial diseases in yaks.Entities:
Keywords: Lactobacillus strains; Leuconostoc pseudomesenteroides; antibacterial activity; safety; yaks
Year: 2018 PMID: 30564222 PMCID: PMC6289064 DOI: 10.3389/fmicb.2018.02987
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Phylogenetic tree based on the 16S rRNA gene sequences using the neighbor-joining method. The three isolated strains were P1, LY1, and LY2. The phylogenetic tree was statistically evaluated using 1000 bootstrap replicates.
Antibiotic susceptibility test for P1, LY1, LY2, and the standard indicator strains.
| Antibiotics | P1 | LY1 | LY2 | |||
|---|---|---|---|---|---|---|
| Vancomycin | R | S | R | R | S | S |
| Norfloxacin | R | S | R | S | R | R |
| Teicoplanin | R | S | R | S | S | S |
| Ciprofloxacin | S | S | R | S | R | R |
| Amoxicillin | S | S | S | R | R | S |
| Roxithromycin | S | S | S | S | R | R |
| Cephalexin | R | S | S | S | I | R |
| Lincomycin | S | S | S | R | R | R |
| Tetracycline | S | S | S | S | S | S |
| Erythromycin | S | S | S | R | R | R |
| Ceftriaxone | R | S | S | S | R | R |
| Enrofloxacin | S | S | S | S | S | S |
FIGURE 2Acid and bile salts tolerance. (A) The tolerance of the isolated strains to acid. (a) P1. (b) LY1. (c) LY2. (B) The tolerance of the isolated strains to bile salts. (a) P1. (b) LY1. (c) LY2.
FIGURE 3The results of the antibacterial experiment. (A) The inhibition zone diameters of P1, LY1, and LY2 against E. coli. (B) The inhibition zone diameters of P1, LY1, and LY2 against S. aureus. (C) The inhibition zone diameters of P1, LY1, and LY2 against S. enteritidis.
FIGURE 4(A) The inhibition zone diameter of LY1 against E. coli. (B) The inhibition zone diameter of P1 against S. aureus. (C) The inhibition zone diameter of LY1 against S. enteritidis.
FIGURE 5Measurement of OD600 values, colony-forming units and pH. (A) OD600 values measured every 2 h for a total of 32 h. (a) P1. (b) LY1. (c) LY2. (B) The colony-forming units were analyzed every 2 h for a total of 32 h, and the number of colonies was calculated as the log10 value of CFU per milliliter. (a) P1. (b) LY1. (c) LY2. (C) pH measurements taken every 2 h for a total of 26 h. (a) P1. (b) LY1. (c) LY2.
FIGURE 6PCR products resulting from amplification with the enterocin P2 primers. (1) P1; (2) LY; (3) LY2; (P) positive control; (N) negative control.
FIGURE 7Body weight changes in the mice of the control and probiotic-treated groups. ● Represent the changes of body weight in the mice of the control group; ■ represent the changes of body weight in the mice of the P1 group; ▲ represent the changes of body weight in the mice of the LY1 group. The values are presented as the mean ± SD (n = 10). A level of P < 0.05 was considered statistically significant.
Performance of different groups of mice after infection with E. coli.
| Virulence trait (s) | Death rate | Diarrhea rate |
|---|---|---|
| Blank control | 0 | 0 |
| Control | 20% | 60% |
| P1-1 | 0 | 30% |
| P1-2 | 0 | 20% |
| LY1-1 | 0 | 30% |
| LY1-2 | 0 | 10% |